PER-010-19已完成未知
A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF CSL112 IN SUBJECTS WITH ACUTE CORONARY SYNDROME
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male or female least 18 years of age
- •2. Evidence of myocardial necrosis, consistent
- •with type I (spontaneous) MI
- •3. No suspicion of acute kidney injury
- •4. Evidence of multivessel coronary artery disease and at least 1 of the following established risk factors:age ≥ 65 years, prior history of MI, diabetes mellitus,or peripheral artery disease
排除标准
- •1. Ongoing hemodynamic instability
- •2. Evidence of hepatobiliary disease
- •3. Evidence of severe chronic kidney disease
- •4. Plan to undergo scheduled coronary artery bypass graft surgery
- •5. Known history of allergies, hypersensitivity, or deficiencies to soy bean, peanut or albumin
研究者
相似试验
招募中
3 期
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]MyositisJPRN-jRCT2031230382Kawai Norisuke270
已完成
3 期
A PHASE 3, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF RELDESEMTIV IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)NL-OMON52262Cytokinetics Inc10
进行中（未招募）
1 期
A MAINTENANCE STUDY OF THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN ULCERATIVE COLITISModerately to Severely Active Ulcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2017-003238-96-ESEli Lilly and Company1,044
进行中（未招募）
1 期
A study to evaluate the efficacy and safety of bimekizumab in subjects with active ankylosing spondylitis.EUCTR2017-003065-95-GBCB Biopharma SR300
进行中（未招募）
1 期
A MAINTENANCE STUDY OF THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN ULCERATIVE COLITISModerately to Severely Active Ulcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2017-003238-96-SKEli Lilly and Company1,044